Healthcare -
Biotechnology - NASDAQ - US
$ 0.7102
-2.83 %
$ 43.3 M
Market Cap
-0.5
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Kronos Bio, Inc.
| Revenue | 9.85 M |
| Cost Of Revenue | 4.26 M |
| Gross Profit | 5.59 M |
| Operating Expenses | 103 M |
| Operating Income | -92.9 M |
| Other Expenses | -6.81 M |
| Net Income | -86.1 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 9.8 | 6.3 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 4.3 | 0 | 4.5 | 4.1 | 4.9 | 0.6 | 0.2 |
| Gross Profit | 5.6 | 6.3 | (4.5) | (4.1) | (4.9) | (0.6) | (0.2) |
| OPERATING INCOME | |||||||
| Operating Expenses | 102.7 | 128.1 | 137.1 | 151.4 | 58.0 | 16.8 | 6.6 |
| Selling, General and Administrative Expenses | 24.6 | 41.7 | 43.4 | 38.5 | 14.8 | 3.4 | 1.6 |
| Research and Development Expenses | 48.7 | 86.4 | 93.7 | 112.9 | 43.2 | 13.4 | 5.0 |
| Operating Income | (92.9) | (121.8) | (137.1) | (151.4) | (58.0) | (16.8) | (6.6) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 3.9 | 0 | 76 K |
| Total Other Income | 6.8 | 9.2 | 3.9 | 0.3 | (30.4) | 0.7 | 76 K |
| Pre-Tax Income | (86.1) | (112.7) | (133.2) | (151.1) | (88.4) | (16.1) | (6.7) |
| NET INCOME | |||||||
| Tax Provision | 0 | 0 | (3.9) | (2.0) | (24.4) | (0.7) | 70.1 K |
| Net Income | (86.1) | (112.7) | (129.3) | (149.1) | (64.1) | (15.4) | (6.7) |
| EPS | 1.43 | 1.95 | 2.3 | 2.72 | 1.19 | 0.29 | 0.24 |